Pharmaceuticals, Biotechnology and Life Sciences
Primary objective of the Mirai study is to evaluate the effectiveness of digital therapeutics to reduce depressive symptoms in adults diagnosed with major depressive disorder (MDD) who are on antidepressant monotherapy
Trial will run fully remotely…
Contract Research Organization Continues Dedicated Oncology Team Expansion
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–#BioTech–Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research or…
DUBLIN–(BUSINESS WIRE)–The “e-Pharmacy: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
This report includes a detailed study of global and regional markets for various types of drugs, therapeutic categories and geographi…
Company conference call and webcast at 4:30 PM ET
AUSTIN, Texas–(BUSINESS WIRE)–$TFFP #earnings–TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products …
Company conference call and webcast at 4:30 PM ET
AUSTIN, Texas–(BUSINESS WIRE)–$TFFP #earnings–TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products …
SANTA BARBARA, Calif.–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Raj Denhoy has been appo…
BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that management will participate in a fireside chat at the Cowen 41st Annual Healthcare Conference on Monday, March 1, 2021 at 2:40 p.m. Eastern Time. The presentation will be …
Virtual, placebo-controlled study indicates AppliedVR’s EaseVRx platform creates high engagement; produces “clinically meaningful” impact on five key pain indicators
LOS ANGELES–(BUSINESS WIRE)–#AppliedVR–AppliedVR, a pioneer advancing the next gen…
– Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D. join as advisors to help guide the company’s immunological cell therapy research efforts –
EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a metagenomics powered gene editing and cell…
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today anno…